why choose us

First received: November 02, 2023

Clinical Trial: Hypoallergenicity of a New Formula in Subjects With Cow's Milk Allergy

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Allergy

Study Type: INTERVENTIONAL


Official Title: Hypoallergenicity of a New Extensively Hydrolyzed Casein-based Liquid Formula in Infants and Children With Cow's Milk Allergy (CMA): a Randomized Study

Brief Summary: Cow's milk protein allergy (CMA) is an immune-mediated reaction which can either be antibody-driven (IgE-mediated) or cell-mediated (non-IgE-mediated) or mixed, and elicits reactions which are reproducible upon re-exposure to cow's milk proteins.Estimates of CMA prevalence depend on the diagnosis procedure used; recently, a meta-analysis stated an overall pooled estimate for 0-1 year old infants of point prevalence of CMA reported by parents of 4.2% (95 % confidence interval (CI): 3.2-5.4),decreasing to…

Read more